101 related articles for article (PubMed ID: 24363325)
1. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis.
Okamoto T; Coultas L; Metcalf D; van Delft MF; Glaser SP; Takiguchi M; Strasser A; Bouillet P; Adams JM; Huang DC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):261-6. PubMed ID: 24363325
[TBL] [Abstract][Full Text] [Related]
2. Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells.
Fiskus W; Cai T; DiNardo CD; Kornblau SM; Borthakur G; Kadia TM; Pemmaraju N; Bose P; Masarova L; Rajapakshe K; Perera D; Coarfa C; Mill CP; Saenz DT; Saenz DN; Sun B; Khoury JD; Shen Y; Konopleva M; Bhalla KN
Blood Cancer J; 2019 Jan; 9(2):4. PubMed ID: 30647404
[TBL] [Abstract][Full Text] [Related]
3. NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death.
Liu Y; Mondello P; Erazo T; Tannan NB; Asgari Z; de Stanchina E; Nanjangud G; Seshan VE; Wang S; Wendel HG; Younes A
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12034-12039. PubMed ID: 30404918
[TBL] [Abstract][Full Text] [Related]
4. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
5. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.
Arai S; Varkaris A; Nouri M; Chen S; Xie L; Balk SP
Elife; 2020 Jun; 9():. PubMed ID: 32484436
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection.
Ebner F; Sedlyarov V; Tasciyan S; Ivin M; Kratochvill F; Gratz N; Kenner L; Villunger A; Sixt M; Kovarik P
J Clin Invest; 2017 Jun; 127(6):2051-2065. PubMed ID: 28504646
[TBL] [Abstract][Full Text] [Related]
7. Donald Metcalf (1929-2014).
Hilton D
Nature; 2015 Jan; 517(7536):554. PubMed ID: 25631437
[No Abstract] [Full Text] [Related]
8. Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53.
Kelly GL; Grabow S; Glaser SP; Fitzsimmons L; Aubrey BJ; Okamoto T; Valente LJ; Robati M; Tai L; Fairlie WD; Lee EF; Lindstrom MS; Wiman KG; Huang DC; Bouillet P; Rowe M; Rickinson AB; Herold MJ; Strasser A
Genes Dev; 2014 Jan; 28(1):58-70. PubMed ID: 24395247
[TBL] [Abstract][Full Text] [Related]
9. Endogenous and imposed determinants of apoptotic vulnerabilities in cancer.
Sarosiek KA; Wood KC
Trends Cancer; 2023 Feb; 9(2):96-110. PubMed ID: 37284233
[TBL] [Abstract][Full Text] [Related]
10. Physiological Functions of Mcl-1: Insights From Genetic Mouse Models.
Chin HS; Fu NY
Front Cell Dev Biol; 2021; 9():704547. PubMed ID: 34336857
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation.
Deo P; Chow SH; Han ML; Speir M; Huang C; Schittenhelm RB; Dhital S; Emery J; Li J; Kile BT; Vince JE; Lawlor KE; Naderer T
Nat Microbiol; 2020 Nov; 5(11):1418-1427. PubMed ID: 32807891
[TBL] [Abstract][Full Text] [Related]
12. Image-Based Analysis of Protein Stability.
Hickman KA; Hariharan S; De Melo J; Ylanko J; Lustig LC; Penn LZ; Andrews DW
Cytometry A; 2020 Apr; 97(4):363-377. PubMed ID: 31774248
[TBL] [Abstract][Full Text] [Related]
13.
Qian YC; Xie YX; Wang CS; Shi ZM; Jiang CF; Tang YY; Qian X; Wang L; Jiang BH
Asian J Androl; 2020; 22(4):414-421. PubMed ID: 31489847
[TBL] [Abstract][Full Text] [Related]
14. Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance.
Yakhni M; Briat A; El Guerrab A; Furtado L; Kwiatkowski F; Miot-Noirault E; Cachin F; Penault-Llorca F; Radosevic-Robin N
Am J Cancer Res; 2019; 9(5):1043-1060. PubMed ID: 31218111
[TBL] [Abstract][Full Text] [Related]
15. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.
Singh R; Letai A; Sarosiek K
Nat Rev Mol Cell Biol; 2019 Mar; 20(3):175-193. PubMed ID: 30655609
[TBL] [Abstract][Full Text] [Related]
16. VDAC2 enables BAX to mediate apoptosis and limit tumor development.
Chin HS; Li MX; Tan IKL; Ninnis RL; Reljic B; Scicluna K; Dagley LF; Sandow JJ; Kelly GL; Samson AL; Chappaz S; Khaw SL; Chang C; Morokoff A; Brinkmann K; Webb A; Hockings C; Hall CM; Kueh AJ; Ryan MT; Kluck RM; Bouillet P; Herold MJ; Gray DHD; Huang DCS; van Delft MF; Dewson G
Nat Commun; 2018 Nov; 9(1):4976. PubMed ID: 30478310
[TBL] [Abstract][Full Text] [Related]
17. Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
Sang B; Zhang YY; Guo ST; Kong LF; Cheng Q; Liu GZ; Thorne RF; Zhang XD; Jin L; Wu M
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11661-E11670. PubMed ID: 30478051
[TBL] [Abstract][Full Text] [Related]
18. Mcl-1 and Bcl-x
Hockings C; Alsop AE; Fennell SC; Lee EF; Fairlie WD; Dewson G; Kluck RM
Cell Death Differ; 2018 Mar; 25(4):721-734. PubMed ID: 29459767
[TBL] [Abstract][Full Text] [Related]
19. A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice.
Jain R; Sheridan JM; Policheni A; Heinlein M; Gandolfo LC; Dewson G; Smyth GK; Sansom SN; Fu NY; Visvader JE; Holländer GA; Strasser A; Gray DHD
Blood; 2017 Dec; 130(23):2504-2515. PubMed ID: 28972012
[TBL] [Abstract][Full Text] [Related]
20. The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice.
Brinkmann K; Grabow S; Hyland CD; Teh CE; Alexander WS; Herold MJ; Strasser A
Cell Death Differ; 2017 Dec; 24(12):2032-2043. PubMed ID: 28800129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
